Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1.]
F.W. Miller.
Classification and prognosis of inflammatory muscle disease.
Rheum Dis Clin North Am, (1994), 20 pp. 811-826
[2.]
L.A. Love, R.L. Leff, D.D. Fraser, I.N. Targoff, M. Dalakas, P.H. Plotz, F.W. Miller.
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Medicine (Baltimore), (1991), 70 pp. 360-374
[3.]
T.A. Medsger, C.V. Oddis.
Inflammatory muscle disease. Clinical features.
2, Mosby, pp. 7.13.1-7.13.14
[4.]
I. Marie, P.Y. Hatron, H. Levesque, E. Hachulla, M.F. Hellot, U. Michon-Pasturel, et al.
Influence of age on characteristics of polymyositis and dermatomyositis in adults.
Medicine, (1999), 78 pp. 139-147
[5.]
P.H. Plotz, F.W. Miller.
Inflammatory muscle disease. Etiology and pathogenesis.
2, Mosby, pp. 7.14.1-7.14.10
[6.]
P.H. Plotz, L.G. Rider, I.N. Targoff, N. Raben, T.P. O`Hanlon, F.W. Miller.
Myositis: Immunologic contributions to understanding cause, pathogenesis and therapy (NIH conference).
Ann Intern Med, (1995), 122 pp. 715-724
[8.]
S.R. Ytterberg.
The relationship of infectious agents to inflammatory myositis.
Rheum Dis Clin North Am, (1994), 20 pp. 995-1.015
[9.]
L.A. Love, F.W. Miller.
Noninfectious environmental agents associated with myopathies.
Curr Opin Rheumatol, (1993), 5 pp. 712-718
[10.]
J.P. Callen.
Dermatomyositis (seminar).
Lancet, (2000), 355 pp. 53-57
[11.]
F.W. Miller.
Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies (Clinical conference).
JAMA, (1993), 270 pp. 1.846-1.849
[12.]
A. Bohan, J.B. Peter.
Polymyositis and dermatomyositis (Part 1).
N Engl J Med, (1975), 292 pp. 344-347
[13.]
I.N. Targoff, F.W. Miller, T.A. Medsger, C.V. Oddis.
Classification criteria for the idiopathic inflammatory myopathies.
Curr Opin Rheumatol, (1997), 9 pp. 527-535
[14.]
P. Cherin.
Treatment of inclusion body myositis.
Curr Opin Rheumatol, (1999), 11 pp. 456-461
[15.]
R.C. Griggs, V. Askanas, S. DiMauro, A. Engel, G. Karpati, J.R. Mendell, L.P. Rowland.
Inclusion body myositis and myopathies.
Ann Neurol, (1995), 38 pp. 705-713
[16.]
S.E. Whitmore, N.B. Rosenshein, T.T. Provost.
Ovarian cancer in patients with dermatomyositis.
Medicine, (1994), 73 pp. 153-160
[17.]
R.D. Sontheimer.
Cutaneous features of classic dermatomyositis and amiopathic dermatomyositis.
Curr Opin Rheumatol, (1999), 11 pp. 475-482
[18.]
M.C. Pickering, M.J. Walport.
Eosinophilic myopathic syndromes.
Curr Opin Rheumatol, (1998), 10 pp. 504-510
[19.]
I.U. Scott, R.M. Siatkowski.
Idiopathic orbital myositis.
Curr Opin Rheumatol, (1997), 9 pp. 504-512
[20.]
J.R. Anderson.
Recent advances in muscular dystrophies and myopathies.
J Clin Pathol, (1995), 48 pp. 597-601
[21.]
R.L. Wortmann.
Metabolic and mitochondrial myopathies.
Curr Opin Rheumatolol, (1999), 11 pp. 462-467
[22.]
J. Arenas, M.R. Gonzalez-Crespo, Y. Campos, A. Cabello, C. García-Benayas, J.J. Gomez-Reino.
Free carnitine and carnitine esters levels in muscle of patients with idiopathic inflammatory myositis.
Arthritis Rheum, (1996), 39 pp. 1.869-1.874
[23.]
R.M. Pascuzzi.
Drugs and toxins associated with myopathies.
Curr Opin Rheumatol, (1998), 10 pp. 511-520
[24.]
S. Yttemberg.
Infectious agents associated with myopathies.
Curr Opin Rheumatol, (1996), 8 pp. 507-513
[25.]
L.J. Catoggio.
Inflammation muscle disease. Management.
2, Mosby, pp. 7.15.1-7.15.6
[26.]
L.S. Rider.
Assesment of disease activity and its sequelae in children and adults with myositis.
Curr Opin Rheumatol, (1996), 8 pp. 495-506
[27.]
C.V. Oddis.
Therapy of inflammatory myopathy.
Rheum Dis Clin North Am, (1994), 20 pp. 899-917
[28.]
E.M. Adams, P.H. Plotz.
The treatment of myositis. How to approach resistant disease.
Rheum Dis Clin North Am, (1995), 21 pp. 179-202
[29.]
L. Villaba, E.M. Adams.
Update on therapy for refractory dermatomyositis and polymiositis.
Curr Opin Rheumatol, (1996), 8 pp. 544-551
[Por su interés general]
Por su interés general recomendamos la lectura de las referenciasbibliográficas 1, 3, 6, 10 y 28.
Copyright ©
2000. Elsevier España, S.L.. Todos los derechos reservados
